Diagnos Inc.
DGNOF
$0.20
$0.00-1.90%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.92% | -37.82% | -47.09% | -32.65% | -21.50% |
| Total Depreciation and Amortization | 1.49% | -2.48% | -1.27% | 0.11% | 10.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.02% | 3.25% | 1.39% | 6.32% | 16.85% |
| Change in Net Operating Assets | 158.43% | -2,001.23% | 170.32% | -247.87% | -134.12% |
| Cash from Operations | -28.40% | -59.33% | -59.71% | -63.34% | -43.27% |
| Capital Expenditure | 19.79% | -29.11% | -78.87% | -22.22% | 52.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.61% | 208.18% | -385.13% | -58,902.63% | -945.55% |
| Cash from Investing | 94.23% | 206.69% | -371.22% | -18,824.37% | -1,035.78% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -558.99% | -576.50% | -549.62% | -185.95% | 31.87% |
| Issuance of Common Stock | -6.33% | -30.58% | 123.46% | 345.25% | 444.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.77% | 8.03% | 1.64% | -8.72% | -14.39% |
| Cash from Financing | -22.70% | -53.03% | 106.54% | 208.24% | 220.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,537.20% | -98.65% | 96.11% | -51.90% | 62.12% |